Improving the Quality of Publications in and Advancing the Paradigms of Clinical and Social Pharmacy Practice Research: the Granada Statements

Overview

Journal Eur J Hosp Pharm

Publisher BMJ Publishing Group

Specialty Pharmacy

Date 2023 Mar 13

PMID 36914239

Authors

Fernando Fernandez-Llimos

Shane Desselle

Derek Stewart

Victoria Garcia-Cardenas

Zaheer-Ud-Din Babar

Christine Bond

Ana Dago

Ramune Jacobsen

Lotte Stig Norgaard

Carlo Polidori

Manuel Sanchez-Polo

Bernardo Santos-Ramos

Natalia G Shcherbakova

Fernanda S Tonin

Affiliations

Soon will be listed here.

Abstract

Pharmacy and pharmaceutical sciences embrace a series of different disciplines. Pharmacy practice has been defined as 'the scientific discipline that studies the different aspects of the practice of pharmacy and its impact on healthcare systems, medicine use, and patient care'. Thus, pharmacy practice studies embrace both clinical pharmacy and social pharmacy elements. Like any other scientific discipline, clinical and social pharmacy practice disseminates research findings using scientific journals. Clinical pharmacy and social pharmacy journal editors have a role in promoting the discipline by enhancing the quality of the articles published. As has occurred in other healthcare areas (ie, medicine and nursing), a group of clinical and social pharmacy practice journal editors gathered in Granada, Spain to discuss how journals could contribute to strengthening pharmacy practice as a discipline. The result of that meeting was compiled in these Granada Statements, which comprise 18 recommendations gathered into six topics: the appropriate use of terminology, impactful abstracts, the required peer reviews, journal scattering, more effective and wiser use of journal and article performance metrics, and authors' selection of the most appropriate pharmacy practice journal to submit their work.

Citing Articles

The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications.

Alves da Costa F, Fernandez-Llimos F, Desselle S, Arnet I, Babar Z, Bond C Int J Clin Pharm. 2024; 47(1):4-7.

PMID: 39699850 PMC: 11741989. DOI: 10.1007/s11096-024-01833-8.

Shalansky S Can J Hosp Pharm. 2024; 77(4):e3744.

PMID: 39664367 PMC: 11616616. DOI: 10.4212/cjhp.3744.

Considerations for conducting a scoping review in pharmacy education.

Lucas C, Desselle S Explor Res Clin Soc Pharm. 2024; 14:100448.

PMID: 38737524 PMC: 11088334. DOI: 10.1016/j.rcsop.2024.100448.

The Granada Statements: An opportunity for the hospital pharmacist to make more impact in the publication world, part 2.

Eriksson T, Polidori C Eur J Hosp Pharm. 2023; 30(6):309.

PMID: 37399272 PMC: 10647853. DOI: 10.1136/ejhpharm-2023-003858.

The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1.

Polidori C, Eriksson T Eur J Hosp Pharm. 2023; 30(4):187.

PMID: 37286310 PMC: 10359779. DOI: 10.1136/ejhpharm-2023-003850.

References

Minguet F, Salgado T, van den Boogerd L, Fernandez-Llimos F . Quality of pharmacy-specific Medical Subject Headings (MeSH) assignment in pharmacy journals indexed in MEDLINE. Res Social Adm Pharm. 2014; 11(5):686-95. DOI: 10.1016/j.sapharm.2014.11.004. View

MacLure K, Paudyal V, Stewart D . Reviewing the literature, how systematic is systematic?. Int J Clin Pharm. 2016; 38(3):685-94. PMC: 4909788. DOI: 10.1007/s11096-016-0288-3. View

Gernant S, Bacci J, Upton C, Ferreri S, McGrath S, Chui M . Three opportunities for standardization: A literature review of the variation among pharmacists' patient care services terminology. Res Social Adm Pharm. 2019; 16(6):766-775. PMC: 7784038. DOI: 10.1016/j.sapharm.2019.08.034. View

Almarsdottir A, Granas A . Social Pharmacy and Clinical Pharmacy-Joining Forces. Pharmacy (Basel). 2017; 4(1). PMC: 5419355. DOI: 10.3390/pharmacy4010001. View

Fernandez-Llimos F . Authors, peer reviewers, and readers: What is expected from each player in collaborative publishing?. Pharm Pract (Granada). 2021; 19(1):2284. PMC: 7822057. DOI: 10.18549/PharmPract.2021.1.2284. View

Aczel B, Szaszi B, Holcombe A . A billion-dollar donation: estimating the cost of researchers' time spent on peer review. Res Integr Peer Rev. 2021; 6(1):14. PMC: 8591820. DOI: 10.1186/s41073-021-00118-2. View

Kronick D . Peer review in 18th-century scientific journalism. JAMA. 1990; 263(10):1321-2. View

Minguet F, van den Boogerd L, Salgado T, Correr C, Fernandez-Llimos F . Characterization of the Medical Subject Headings thesaurus for pharmacy. Am J Health Syst Pharm. 2014; 71(22):1965-72. DOI: 10.2146/ajhp140073. View

Mendes A, Tonin F, Mainka F, Pontarolo R, Fernandez-Llimos F . Publication speed in pharmacy practice journals: A comparative analysis. PLoS One. 2021; 16(6):e0253713. PMC: 8241115. DOI: 10.1371/journal.pone.0253713. View

10.

Dougherty M, Horne Z . Citation counts and journal impact factors do not capture some indicators of research quality in the behavioural and brain sciences. R Soc Open Sci. 2022; 9(8):220334. PMC: 9382220. DOI: 10.1098/rsos.220334. View

11.

BAILAR 3rd J, Patterson K . Journal peer review. The need for a research agenda. N Engl J Med. 1985; 312(10):654-7. DOI: 10.1056/NEJM198503073121023. View

12.

Rossner M, Van Epps H, Hill E . Show me the data. J Cell Biol. 2007; 179(6):1091-2. PMC: 2140038. DOI: 10.1083/jcb.200711140. View

13.

Fernandez-Llimos F, Garcia-Cardenas V . The importance of using standardized terminology in titles and abstracts of pharmacy practice articles. Res Social Adm Pharm. 2022; :190-191. DOI: 10.1016/j.sapharm.2022.08.017. View

14.

Mendes A, Tonin F, Buzzi M, Pontarolo R, Fernandez-Llimos F . Mapping pharmacy journals: A lexicographic analysis. Res Social Adm Pharm. 2019; 15(12):1464-1471. DOI: 10.1016/j.sapharm.2019.01.011. View

15.

Desselle S, Chen A, Amin M, Aslani P, Dawoud D, Miller M . Generosity, collegiality, and scientific accuracy when writing and reviewing original research. Res Social Adm Pharm. 2019; 16(2):261-265. DOI: 10.1016/j.sapharm.2019.04.054. View

16.

van Mil J, Henman M . Terminology, the importance of defining. Int J Clin Pharm. 2016; 38(3):709-13. DOI: 10.1007/s11096-016-0294-5. View

17.

Al Saeedy D, Thomas D, Palaian S . Visibility of evidence-based pharmacy on PubMed - Identity crisis?. Res Social Adm Pharm. 2019; 15(11):1374. DOI: 10.1016/j.sapharm.2019.03.004. View

18.

Irwin A, Rackham D . Comparison of the time-to-indexing in PubMed between biomedical journals according to impact factor, discipline, and focus. Res Social Adm Pharm. 2016; 13(2):389-393. DOI: 10.1016/j.sapharm.2016.04.006. View

19.

Huisman J, Smits J . Duration and quality of the peer review process: the author's perspective. Scientometrics. 2017; 113(1):633-650. PMC: 5629227. DOI: 10.1007/s11192-017-2310-5. View

20.

Fernandez-Llimos F, Mendes A, Tonin F . Confusing terminology used in the abbreviation of pharmacy journal names. Res Social Adm Pharm. 2022; 18(8):3463-3465. DOI: 10.1016/j.sapharm.2022.01.003. View